The Asian Scientist 100
Di Li
Institution
National Astronomical Observatories of the Chinese Academy of Sciences
Country
China
Field
Aerospace & Astronomy
Li received the Marcel Grossmann Award for his pioneering contributions in the field of fast radio bursts. Li is the first scientist in China to receive this prize for research conducted within China.
(Photo: The Paper)
AWARDS
- Marcel Grossmann Award
Related articles
Desert Scorpion Inspires Erosion-Resistant Surfaces That Resist Wear & Tear
Taking inspiration from the bionic shield of the yellow fattail scorpion, scientists have developed a new way to protect the moving parts of machinery from wear and tear.
Ulcer-Causing Helicobacter Pylori Survives In Our Acidic Gut By Turning It Neutral
Researchers at CUHK are slowly creating a blueprint to understand how the H. pylori pathogen stays alive and well in the acidic guts of half the world's population.
Study: Chemical Weapon In Spider Silk Repels Ant Attack
Researchers have shown for the first time how Golden orb web spiders add a chemical to their web silk to repel invading ants.
Cell Therapy May Slow Down Age-Macular Degeneration
A Phase II clinical trial for the treatment of a severe form of eye disease is the first study to show the benefit of a therapy to slow the progression of vision loss.
The Self-Made Eye: Formation Of Optic Cup From Stem Cells
A new report describes how mouse embryonic stem cells (ESCs) are able to differentiate and assemble into an optic cup of the eye.
Green Tea, Tai Chi May Be Beneficial After Menopause
Tea has for generations been an integral infusion worldwide, carrying both epicurean and economic significance. But does it impart health benefits?
Researchers Create Nanopatch To Regenerate Heart Tissue
A group of researchers at Brown University and the India Institute of Technology Kanpur (IITK) have used polymer nanofibers to regenerate heart tissue cells in vitro.
Study: Six Genetic Variants Linked To Type 2 Diabetes In South Asians
A team of international researchers examined the genomic DNA of South Asian patients with type 2 diabetes, identifying six genetic variants associated with the disease.
Takeda’s TAK-385 In Phase II Trials For Endometriosis, Uterine Fibroids
Takeda Pharma announced today that it has initiated Phase II clinical trials of TAK-385 in Japan for the treatment of endometriosis and uterine fibroids.